Dana-Farber Researcher Selected to Join the Pew Scholars Program - Report - MDSpire
Advertisement
Dana-Farber Researcher Selected to Join the Pew Scholars Program
The Pew Charitable Trusts announced that Xin Gu, PhD, of Dana-Farber Cancer Institute, is among 21 researchers who have been selected to join the Pew Scholars Program in the Biomedical Sciences.
Clinical Report: Dana-Farber Researcher Selected to Join the Pew Scholars Program
Overview
Xin Gu, PhD, from Dana-Farber Cancer Institute, has been selected as one of 21 Pew Scholars in the Biomedical Sciences. Gu's research will focus on a newly discovered pathway for protein degradation that regulates gene activity.
Background
The Pew Scholars Program supports early-career scientists in their pursuit of innovative research in the biomedical sciences. Protein degradation pathways are essential for maintaining cellular functions.
Data Highlights
No numerical data or trial data available in the source material.
Key Findings
Xin Gu, PhD, is a principal investigator at Dana-Farber and an assistant professor at Harvard Medical School.
Gu's project will explore a novel pathway for selective protein degradation that regulates gene activity.
This research builds on the lab's efforts to maintain healthy protein balance in cells.
The 2026 class of Pew Scholars was selected from over 200 applicants across the United States.
Clinical Implications
Understanding these pathways may enhance the development of effective treatments for malignancies.
Conclusion
Xin Gu's selection as a Pew Scholar reflects the ongoing support for innovative research in the biomedical sciences.
Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.
